Semaglutide, among other antidiabetic drugs, has shown an association with cancer as it alters the rates of tumorigenesis and proliferation
When to Check Your Labs If youre starting tirzepatide with an abnormal baseline lipid panel, most providers recommend rechecking at three to four months into treatment, after youve had time to reach a meaningful dose and see early weight loss
Weight loss medications such as semaglutide (Ozempic/Wegovy) result in significant weight loss
Toxin Overload From pollutants to heavy metals, your liver works nonstop to clean your system
AMCP Nexus in focus: Exploring Primes GLP-1 research in depth Ben Urick, senior director of health outcomes, and Landon Marshall, health outcomes research principal, share more about their educational session and research poster on GLP-1s Prior to the release of Prime Therapeutics (Prime) latest cost-of-care data from its ongoing real-world research on glucagon-like peptide-1 (GLP-1) agonist drugs, Prime researchers presented findings from the Year-2 adherence and persistence study as a research poster and an education session at Academy of Managed Care Pharmacy (AMCP) Nexus 2024 in Las Vegas, Nevada
